Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mednovo Group is a comprehensive medical technology organization based in Beijing, China, that provides integrated services and products for the interventional medical device industry. The group operates through two primary divisions: a high-tech manufacturing arm focused on cardiovascular and electrophysiology devices, and a leading Contract Research Organization (CRO) specializing in clinical trials and regulatory affairs. Its product portfolio includes advanced solutions such as the V-CORES drug-eluting stent system and 3D cardiac mapping technologies. As a CRO, Mednovo Group has supported hundreds of domestic and international companies in navigating the NMPA regulatory pathway. The company is dedicated to advancing minimally invasive therapies and accelerating the entry of innovative medical devices into the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mednovo Group.